These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 15638159)
1. Chromatographic methods for the separation of biocompatible iron chelators from their synthetic precursors and iron chelates. Kovaríková P; Mokrý M; Klime J; Vávrová K J Sep Sci; 2004 Dec; 27(17-18):1503-10. PubMed ID: 15638159 [TBL] [Abstract][Full Text] [Related]
2. The interaction of pyridoxal isonicotinoyl hydrazone (PIH) and salicylaldehyde isonicotinoyl hydrazone (SIH) with iron. Chen YL; Kong X; Xie Y; Hider RC J Inorg Biochem; 2018 Mar; 180():194-203. PubMed ID: 29329026 [TBL] [Abstract][Full Text] [Related]
3. HPLC determination of a novel aroylhydrazone iron chelator (o-108) in rabbit plasma and its application to a pilot pharmacokinetic study. Kovaríková P; Klimes J; Sterba M; Popelová O; Gersl V; Ponka P J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jul; 838(2):107-12. PubMed ID: 16725389 [TBL] [Abstract][Full Text] [Related]
4. Investigation of the stability of aromatic hydrazones in plasma and related biological material. Kovaríková P; Mrkvicková Z; Klimes J J Pharm Biomed Anal; 2008 Jun; 47(2):360-70. PubMed ID: 18294799 [TBL] [Abstract][Full Text] [Related]
5. HPLC study on stability of pyridoxal isonicotinoyl hydrazone. Kovaríková P; Mokrý M; Klimes J; Vávrová K J Pharm Biomed Anal; 2006 Jan; 40(1):105-12. PubMed ID: 16061341 [TBL] [Abstract][Full Text] [Related]
6. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents II: the mechanism of action of ligands derived from salicylaldehyde benzoyl hydrazone and 2-hydroxy-1-naphthylaldehyde benzoyl hydrazone. Richardson DR; Milnes K Blood; 1997 Apr; 89(8):3025-38. PubMed ID: 9108424 [TBL] [Abstract][Full Text] [Related]
7. Development of high-performance liquid chromatographic determination of salicylaldehyde isonicotinoyl hydrazone in rabbit plasma and application of this method to an in vivo study. Kovaríková P; Klimes J; Stĕrba M; Popelová O; Mokrý M; Gersl V; Ponka P J Sep Sci; 2005 Aug; 28(12):1300-6. PubMed ID: 16138682 [TBL] [Abstract][Full Text] [Related]
8. LC-UV/MS methods for the analysis of prochelator-boronyl salicylaldehyde isonicotinoyl hydrazone (BSIH) and its active chelator salicylaldehyde isonicotinoyl hydrazone (SIH). Bureš J; Jansová H; Stariat J; Filipský T; Mladěnka P; Šimůnek T; Kučera R; Klimeš J; Wang Q; Franz KJ; Kovaříková P J Pharm Biomed Anal; 2015 Feb; 105():55-63. PubMed ID: 25527982 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of HPLC-DAD methods for the analysis of two novel iron chelators with potent anti-cancer activity. Mrkvicková Z; Kovaríková P; Klimes J; Kalinowski D; Richardson DR J Pharm Biomed Anal; 2007 Mar; 43(4):1343-51. PubMed ID: 17166684 [TBL] [Abstract][Full Text] [Related]
10. Development of novel aroylhydrazone ligands for iron chelation therapy: 2-pyridylcarboxaldehyde isonicotinoyl hydrazone analogs. Becker E; Richardson DR J Lab Clin Med; 1999 Nov; 134(5):510-21. PubMed ID: 10560945 [TBL] [Abstract][Full Text] [Related]
11. Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity. Simunek T; Sterba M; Popelova O; Kaiserova H; Potacova A; Adamcova M; Mazurova Y; Ponka P; Gersl V Hemoglobin; 2008; 32(1-2):207-15. PubMed ID: 18274998 [TBL] [Abstract][Full Text] [Related]
12. Pyridoxal isonicotinoyl hydrazone analogs induce apoptosis in hematopoietic cells due to their iron-chelating properties. Buss JL; Neuzil J; Gellert N; Weber C; Ponka P Biochem Pharmacol; 2003 Jan; 65(2):161-72. PubMed ID: 12504792 [TBL] [Abstract][Full Text] [Related]
13. Iron chelators of the pyridoxal isonicotinoyl hydrazone class. Relationship of the lipophilicity of the apochelator to its ability to mobilise iron from reticulocytes in vitro. Ponka P; Richardson DR; Edward JT; Chubb FL Can J Physiol Pharmacol; 1994 Jun; 72(6):659-66. PubMed ID: 7954097 [TBL] [Abstract][Full Text] [Related]
15. Hydrolysis of pyridoxal isonicotinoyl hydrazone and its analogs. Buss JL; Ponka P Biochim Biophys Acta; 2003 Jan; 1619(2):177-86. PubMed ID: 12527114 [TBL] [Abstract][Full Text] [Related]
16. Biliary iron excretion in rats following treatment with analogs of pyridoxal isonicotinoyl hydrazone. Bláha K; Cikrt M; Nerudová J; Ponka HF Blood; 1998 Jun; 91(11):4368-72. PubMed ID: 9596686 [TBL] [Abstract][Full Text] [Related]
17. EPR spin trapping and 2-deoxyribose degradation studies of the effect of pyridoxal isonicotinoyl hydrazone (PIH) on *OH formation by the Fenton reaction. Hermes-Lima M; Santos NC; Yan J; Andrews M; Schulman HM; Ponka P Biochim Biophys Acta; 1999 Feb; 1426(3):475-82. PubMed ID: 10076064 [TBL] [Abstract][Full Text] [Related]
18. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Richardson DR; Tran EH; Ponka P Blood; 1995 Dec; 86(11):4295-306. PubMed ID: 7492790 [TBL] [Abstract][Full Text] [Related]
19. Mobilization of intracellular iron by analogs of pyridoxal isonicotinoyl hydrazone (PIH) is determined by the membrane permeability of the iron-chelator complexes. Buss JL; Arduini E; Ponka P Biochem Pharmacol; 2002 Dec; 64(12):1689-701. PubMed ID: 12445858 [TBL] [Abstract][Full Text] [Related]